l carnitine tmao nature medicine 2013 koeth Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy γ–Butyrobetaine is a pro-atherogenic intermediate

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Gut Microbiome Derived Metabolite Trimethylamine N Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans Hypertension Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism

SKU: 75729397498 · From metalmesh.com.au